{"gene":"SP9","run_date":"2026-06-10T07:46:38","timeline":{"discoveries":[{"year":2004,"finding":"Sp9 (and Sp8) are expressed in the apical ectodermal ridge (AER) and act as positive regulators of Fgf8 expression during limb outgrowth; they are ectodermal targets of Fgf10 signaling from the mesenchyme. Dominant-negative overexpression in chick and morpholino knockdown in zebrafish both abolish Fgf8 expression and impair limb outgrowth, demonstrating their requirement. Wnt/beta-catenin signaling positively regulates Sp8 but not Sp9.","method":"Embryological and genetic analyses, chick overexpression and dominant-negative approaches, zebrafish morpholino knockdown, in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal approaches (gain-of-function, dominant-negative, morpholino KD) replicated across two model organisms with defined molecular readout (Fgf8 expression)","pmids":["15358670"],"is_preprint":false},{"year":2016,"finding":"Sp9 is expressed in LGE progenitors and maintained in postmitotic striatopallidal MSNs. Sp9-null mice lose most striatopallidal (D2-type) MSNs due to decreased proliferation of their progenitors and increased Bax-dependent apoptosis, while striatonigral neurons are largely unaffected. ChIP-qPCR shows Ascl1 directly binds the Sp9 promoter. RNA-seq/ISH reveal Sp9 promotes expression of Adora2a, P2ry1, Gpr6, and Grik3 in the LGE and striatum.","method":"Sp9-null mouse genetic analysis, ChIP-qPCR, RNA-seq, in situ hybridization, immunofluorescence","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic null mouse with defined cellular phenotype, ChIP for upstream regulator, RNA-seq for downstream targets, multiple orthogonal methods in one study","pmids":["27452460"],"is_preprint":false},{"year":2018,"finding":"SP8 and SP9 coordinately drive expression of the transcription factor Six3 in a spatially restricted domain of the LGE subventricular zone, which is required for D2 MSN production. ChIP-Seq demonstrates SP9 directly binds the promoter and a putative enhancer of Six3. Conditional deletion of Sp8 and Sp9 causes loss of virtually all D2 MSNs due to reduced neurogenesis; Six3 conditional deletion phenocopies this.","method":"Conditional knockout mouse genetics (Sp8/Sp9 double mutants), ChIP-Seq (SP9), RNA-seq, in situ hybridization, genetic epistasis (Six3 conditional KO)","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct SP9 ChIP-Seq binding to Six3 locus, genetic epistasis via Six3 conditional KO phenocopy, and conditional double KO with defined molecular and cellular readouts","pmids":["29967281"],"is_preprint":false},{"year":2018,"finding":"Sp8 and Sp9 are co-expressed in neuroblasts and interneurons of the V-SVZ-RMS-OB system. Although Sp9-null mice show no major OB interneuron defect alone, conditional deletion of both Sp8 and Sp9 severely reduces OB interneuron number through defects in neuronal differentiation, tangential and radial migration, and increased cell death. Sp8/Sp9 double mutants fail to express Prokr2 and Tshz1 in newly born neuroblasts.","method":"Conditional knockout mouse genetics (Sp8/Sp9 single and double mutants), RNA-Seq, RNA in situ hybridization, cell counting, migration analysis","journal":"Cerebral cortex (New York, N.Y. : 1991)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic null and conditional double KO with defined cellular phenotypes (differentiation, migration, apoptosis) and molecular targets identified by RNA-seq","pmids":["28981617"],"is_preprint":false},{"year":2019,"finding":"SP9 is expressed in the MGE subventricular zone and in MGE-derived migrating interneurons. Sp9-null and conditional mutant mice show ~50% reduction in MGE-derived cortical interneurons, ectopic aggregation of MGE-derived neurons in the embryonic ventral telencephalon, and an increased SST+/PV+ ratio. ChIP-Seq and RNA-Seq identify SP9 as a direct transcriptional regulator of Arx, Lhx6, Lhx8, Nkx2-1, Zeb2 (interneuron development factors) and Ackr3, Epha3, St18 (migration genes).","method":"Sp9-null and conditional knockout mouse genetics, SP9 ChIP-Seq, RNA-Seq, immunofluorescence, in situ hybridization","journal":"Cerebral cortex (New York, N.Y. : 1991)","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — SP9 ChIP-Seq defines direct genomic targets, combined with null/conditional KO phenotypic analysis and RNA-seq in single rigorous study","pmids":["29878134"],"is_preprint":false},{"year":2019,"finding":"SP8 and SP9 are co-expressed in the SVZ of the dorsal CGE. Conditional knockout of Sp8/9 (Gsx2-Cre or Dlx5/6-CIE lines) causes severe loss of CGE-derived cortical interneurons and migration defects (longer leading processes, ectopic accumulation in the CGE). Sp8/9 coordinately repress expression of Pak3, Robo1, and Slit1 to regulate CGE-derived interneuron migration.","method":"Conditional knockout mouse genetics (Gsx2-Cre and Dlx5/6-CIE lines), immunofluorescence, in situ hybridization, RNA-Seq","journal":"The Journal of comparative neurology","confidence":"High","confidence_rationale":"Tier 2 / Strong — two independent Cre lines both produce consistent phenotypes, molecular targets identified, multiple orthogonal methods","pmids":["31070778"],"is_preprint":false},{"year":2019,"finding":"SP8 protein is upregulated in MGE mantle zone in Sp9-null mutants. Combined Sp8/Sp9 conditional knockout results in severe loss of PV+ cortical interneurons due to tangential migration defects, more severe than Sp9 single mutants, indicating Sp8 and Sp9 cooperate. Sp8/Sp9 activity regulates MGE-derived cortical interneuron migration at least through controlling EphA3, Ppp2r2c, and Rasgef1b expression.","method":"Sp9-null and Sp8/Sp9 conditional knockout mouse genetics, immunofluorescence, RNA-Seq, migration analysis","journal":"Frontiers in molecular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional double KO with defined migration phenotype and molecular targets, single lab, no ChIP confirmation of direct regulation","pmids":["31001083"],"is_preprint":false},{"year":2022,"finding":"Sp9-positive LGE progenitors produce both D1-MSNs and D2-MSNs, but Sp9 expression is rapidly downregulated in postmitotic D1-MSNs. Sustained Sp9 expression (gain-of-function) in LGE progenitors and descendants promotes D2-MSN identity and represses D1-MSN identity, causing an imbalance between D1- and D2-MSNs. Fate-changed D2-like MSNs survive normally in adulthood.","method":"Genetic fate mapping, gain-of-function (sustained Sp9 expression) mouse model, immunofluorescence, in situ hybridization","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo gain-of-function with defined cell-fate outcome, single lab, two orthogonal methods (fate mapping + immunofluorescence)","pmids":["35773249"],"is_preprint":false},{"year":2024,"finding":"De novo heterozygous SP9 variants cause interneuronopathy. SP9 missense variants affecting glutamate 378 (within the conserved DNA-binding domain) result in severe epileptic encephalopathy via hypomorphic and neomorphic DNA-binding effects, demonstrated by in vitro assays. SP9 loss-of-function variants result in milder neurodevelopmental phenotype. This establishes that altered SP9 DNA-binding activity directly causes disease.","method":"In silico and in vitro assays of SP9 variant DNA-binding activity, patient cohort variant analysis, international data-sharing","journal":"Genetics in medicine : official journal of the American College of Medical Genetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro DNA-binding assays for specific variants, single study, mechanistic distinction between hypomorphic/neomorphic effects established experimentally","pmids":["38288683"],"is_preprint":false},{"year":2025,"finding":"Sp9 was identified as a key regulator of visual thalamic fate through in silico predictions and in vivo perturbations in a spatiotemporal single-cell multiomic atlas of the embryonic mouse thalamus, indicating Sp9 governs sensory lineage specification within the thalamus.","method":"Single-cell multiomic atlas, spatial transcriptomics, barcoding-based lineage tracing, in vivo perturbations","journal":"bioRxiv (preprint)","confidence":"Low","confidence_rationale":"Tier 3 / Weak — preprint, in vivo perturbations described but methods are not detailed in the abstract, single study","pmids":["bio_10.1101_2025.07.17.665342"],"is_preprint":true}],"current_model":"SP9 is a Krüppel-like/SP-family zinc-finger transcription factor that directly binds DNA (including the Six3 locus and other target promoters/enhancers) to regulate multiple steps of GABAergic interneuron and medium spiny neuron development: it controls progenitor proliferation, neuronal differentiation, tangential migration, and cell survival in LGE, MGE, and CGE progenitor domains, promotes D2-MSN identity while repressing D1-MSN identity, and is itself transcriptionally activated by Ascl1 (via direct promoter binding) and by Fgf10/Wnt signaling during limb/AER development; loss-of-function or neomorphic mutations in its conserved DNA-binding domain cause human interneuronopathy."},"narrative":{"mechanistic_narrative":"SP9 is an SP-family zinc-finger transcription factor that directly binds DNA to orchestrate multiple steps of GABAergic neuron development across the ventral telencephalon [PMID:29967281, PMID:29878134]. In the lateral ganglionic eminence it acts together with SP8 to drive a Six3-dependent neurogenic program — SP9 binds the Six3 promoter and a putative enhancer by ChIP-Seq — that is required to generate striatopallidal D2-type medium spiny neurons; loss of Sp9 (or of both Sp8 and Sp9) eliminates most D2-MSNs through reduced progenitor proliferation and Bax-dependent apoptosis, while sustained SP9 expression promotes D2-MSN identity and represses D1-MSN identity [PMID:27452460, PMID:29967281, PMID:35773249]. SP9 is itself a direct downstream target of Ascl1, which binds its promoter [PMID:27452460]. In the medial and caudal ganglionic eminences SP9, with SP8, controls cortical interneuron number, subtype balance, and tangential migration, acting as a direct transcriptional regulator of interneuron-fate genes (Arx, Lhx6, Lhx8, Nkx2-1, Zeb2) and migration genes (Ackr3, Epha3, St18), and repressing the migration regulators Pak3, Robo1, and Slit1 [PMID:29878134, PMID:31070778, PMID:31001083]. The same SP8/SP9 partnership governs olfactory bulb interneuron differentiation and migration through targets including Prokr2 and Tshz1 [PMID:28981617]. De novo heterozygous SP9 variants affecting glutamate 378 in the conserved DNA-binding domain cause severe epileptic encephalopathy through hypomorphic and neomorphic effects on DNA binding, establishing that altered SP9 DNA-binding activity directly causes human interneuronopathy [PMID:38288683]. Beyond the nervous system, SP9 functions in the apical ectodermal ridge as a positive regulator of Fgf8 expression downstream of Fgf10 signaling during limb outgrowth [PMID:15358670].","teleology":[{"year":2004,"claim":"Established the first developmental function of Sp9, placing it in the Fgf10→ectoderm→Fgf8 relay that sustains limb outgrowth.","evidence":"Chick gain-of-function and dominant-negative, zebrafish morpholino knockdown, in situ hybridization, with Fgf8 expression as readout","pmids":["15358670"],"confidence":"High","gaps":["Direct DNA targets at the Fgf8 locus not defined","Relationship to its later neural roles unaddressed","No mammalian limb genetics"]},{"year":2016,"claim":"Defined Sp9 as required for striatopallidal D2-MSN production and identified it as a direct Ascl1 target, linking an upstream proneural input to a specific neuronal output.","evidence":"Sp9-null mouse phenotyping, ChIP-qPCR (Ascl1 on Sp9 promoter), RNA-seq and ISH for downstream genes","pmids":["27452460"],"confidence":"High","gaps":["Direct SP9 DNA targets not yet mapped in this study","Mechanism distinguishing proliferation from survival defects unresolved"]},{"year":2018,"claim":"Resolved the molecular logic of D2-MSN neurogenesis by showing SP8/SP9 directly activate Six3, with Six3 deletion phenocopying the double mutant.","evidence":"Sp8/Sp9 conditional double KO, SP9 ChIP-Seq on Six3 promoter/enhancer, RNA-seq, Six3 conditional KO epistasis","pmids":["29967281"],"confidence":"High","gaps":["Whether SP8 and SP9 bind cooperatively or independently at Six3 not resolved","Full SP9 cistrome beyond Six3 not enumerated here"]},{"year":2018,"claim":"Extended SP8/SP9 function to olfactory bulb interneurons, showing redundancy and a role in differentiation, migration, and survival.","evidence":"Sp8/Sp9 single and conditional double KO mice, RNA-seq, ISH, cell counting, migration analysis","pmids":["28981617"],"confidence":"High","gaps":["Direct vs indirect regulation of Prokr2/Tshz1 not established by ChIP","Single-mutant tolerance reflects unquantified redundancy"]},{"year":2019,"claim":"Mapped the direct SP9 cistrome in the MGE, establishing it as a hub controlling interneuron-fate and migration gene programs.","evidence":"Sp9-null/conditional KO, SP9 ChIP-Seq, RNA-Seq, immunofluorescence, ISH","pmids":["29878134"],"confidence":"High","gaps":["Which targets drive subtype (SST/PV) balance vs migration not dissected","Cofactors at SP9-bound sites unidentified"]},{"year":2019,"claim":"Showed SP8/SP9 act in the CGE as repressors of a Slit/Robo migration module, broadening their domain of action to a third progenitor zone.","evidence":"Conditional KO with two independent Cre lines (Gsx2-Cre, Dlx5/6-CIE), immunofluorescence, ISH, RNA-Seq","pmids":["31070778"],"confidence":"High","gaps":["Direct binding to Pak3/Robo1/Slit1 loci not shown","Mechanism of repression unknown"]},{"year":2019,"claim":"Demonstrated functional cooperation between Sp8 and Sp9 in MGE-derived PV interneuron migration, with SP8 upregulation partly compensating for Sp9 loss.","evidence":"Sp9-null and Sp8/Sp9 conditional KO mice, immunofluorescence, RNA-Seq, migration analysis","pmids":["31001083"],"confidence":"Medium","gaps":["No ChIP confirmation of direct regulation of EphA3/Ppp2r2c/Rasgef1b","Single lab"]},{"year":2022,"claim":"Established that the level and persistence of SP9 acts as a switch between D2 and D1 MSN identity rather than only affecting MSN number.","evidence":"Genetic fate mapping and sustained Sp9 gain-of-function mouse model, immunofluorescence, ISH","pmids":["35773249"],"confidence":"Medium","gaps":["Direct repressive targets enforcing D1 identity not identified","Single lab, no biochemical mechanism for the switch"]},{"year":2024,"claim":"Connected SP9 DNA-binding activity directly to human disease, distinguishing hypomorphic loss-of-function from neomorphic missense effects.","evidence":"Patient cohort variant analysis with in silico and in vitro DNA-binding assays for E378 and LoF variants","pmids":["38288683"],"confidence":"Medium","gaps":["Neomorphic target rewiring not defined at genomic scale","No animal model of the E378 variant","Single study"]},{"year":2025,"claim":"Proposed an additional role for Sp9 in visual thalamic sensory lineage specification, outside the established telencephalic GABAergic program.","evidence":"Single-cell multiomic atlas, spatial transcriptomics, lineage barcoding and in vivo perturbations (preprint)","pmids":["bio_10.1101_2025.07.17.665342"],"confidence":"Low","gaps":["Preprint, perturbation methods not detailed","Direct targets in thalamus unknown","Not independently confirmed"]},{"year":null,"claim":"How SP9 and SP8 physically partition direct genomic targets, and what cofactors mediate their context-specific activation versus repression, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No reported SP8–SP9 biochemical interaction map","Cofactor identity at SP9 binding sites unknown","Structural basis of neomorphic DNA binding undetermined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,4,8]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2,4,5]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,4]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,2,4,5]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,4]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[8]}],"complexes":[],"partners":["SP8","ASCL1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P0CG40","full_name":"Transcription factor Sp9","aliases":[],"length_aa":484,"mass_kda":48.9,"function":"Transcription factor which plays a key role in limb development. Positively regulates FGF8 expression in the apical ectodermal ridge (AER) and contributes to limb outgrowth in embryos (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P0CG40/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SP9","classification":"Not Classified","n_dependent_lines":30,"n_total_lines":1208,"dependency_fraction":0.024834437086092714},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SP9","total_profiled":1310},"omim":[{"mim_id":"621003","title":"TRANSCRIPTION FACTOR Sp9; SP9","url":"https://www.omim.org/entry/621003"},{"mim_id":"102545","title":"ACTIN, GAMMA-2, SMOOTH MUSCLE, ENTERIC; ACTG2","url":"https://www.omim.org/entry/102545"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Mitochondria","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":3.9},{"tissue":"fallopian tube","ntpm":1.7}],"url":"https://www.proteinatlas.org/search/SP9"},"hgnc":{"alias_symbol":["ZNF990"],"prev_symbol":[]},"alphafold":{"accession":"P0CG40","domains":[{"cath_id":"-","chopping":"308-359","consensus_level":"medium","plddt":65.3306,"start":308,"end":359}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P0CG40","model_url":"https://alphafold.ebi.ac.uk/files/AF-P0CG40-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P0CG40-F1-predicted_aligned_error_v6.png","plddt_mean":48.34},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SP9","jax_strain_url":"https://www.jax.org/strain/search?query=SP9"},"sequence":{"accession":"P0CG40","fasta_url":"https://rest.uniprot.org/uniprotkb/P0CG40.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P0CG40/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P0CG40"}},"corpus_meta":[{"pmid":"15358670","id":"PMC_15358670","title":"Sp8 and Sp9, two closely related buttonhead-like transcription factors, regulate Fgf8 expression and limb outgrowth in vertebrate embryos.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15358670","citation_count":137,"is_preprint":false},{"pmid":"27452460","id":"PMC_27452460","title":"The Zinc Finger Transcription Factor Sp9 Is Required for the Development of Striatopallidal Projection Neurons.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/27452460","citation_count":61,"is_preprint":false},{"pmid":"29967281","id":"PMC_29967281","title":"SP8 and SP9 coordinately promote D2-type medium spiny neuron production by activating Six3 expression.","date":"2018","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/29967281","citation_count":55,"is_preprint":false},{"pmid":"28981617","id":"PMC_28981617","title":"Transcription Factors Sp8 and Sp9 Coordinately Regulate Olfactory Bulb Interneuron Development.","date":"2018","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/28981617","citation_count":55,"is_preprint":false},{"pmid":"29878134","id":"PMC_29878134","title":"Sp9 Regulates Medial Ganglionic Eminence-Derived Cortical Interneuron Development.","date":"2019","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/29878134","citation_count":37,"is_preprint":false},{"pmid":"31070778","id":"PMC_31070778","title":"Transcription factors Sp8 and Sp9 regulate the development of caudal ganglionic eminence-derived cortical interneurons.","date":"2019","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31070778","citation_count":29,"is_preprint":false},{"pmid":"29881660","id":"PMC_29881660","title":"Heliomycin and tetracinomycin D: anthraquinone derivatives with histone deacetylase inhibitory activity from marine sponge-associated Streptomyces sp. SP9.","date":"2018","source":"3 Biotech","url":"https://pubmed.ncbi.nlm.nih.gov/29881660","citation_count":15,"is_preprint":false},{"pmid":"31001083","id":"PMC_31001083","title":"Transcription Factors Sp8 and Sp9 Regulate Medial Ganglionic Eminence-Derived Cortical Interneuron Migration.","date":"2019","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31001083","citation_count":11,"is_preprint":false},{"pmid":"35773249","id":"PMC_35773249","title":"Transcription factor Sp9 is a negative regulator of D1-type MSN development.","date":"2022","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/35773249","citation_count":9,"is_preprint":false},{"pmid":"38501924","id":"PMC_38501924","title":"The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3 and Sp9 and their impact on wild-type HBV replication.","date":"2024","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/38501924","citation_count":8,"is_preprint":false},{"pmid":"37539266","id":"PMC_37539266","title":"Diversity, astaxanthin production, and genomic analysis of Rhodotorula paludigena SP9-15.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/37539266","citation_count":7,"is_preprint":false},{"pmid":"38288683","id":"PMC_38288683","title":"De novo variants in SP9 cause a novel form of interneuronopathy characterized by intellectual disability, autism spectrum disorder, and epilepsy with variable expressivity.","date":"2024","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/38288683","citation_count":3,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.17.665342","title":"Early lineage divergence segregates sensory and non-sensory thalamic circuits","date":"2025-07-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.17.665342","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.17.643665","title":"Electrical Spinal Imaging (ESI): Analysing spinal cord activity with non-invasive, high-resolution mapping","date":"2025-03-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.17.643665","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":8910,"output_tokens":3045,"usd":0.036202,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10409,"output_tokens":3384,"usd":0.068322,"stage2_stop_reason":"end_turn"},"total_usd":0.104524,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2004,\n      \"finding\": \"Sp9 (and Sp8) are expressed in the apical ectodermal ridge (AER) and act as positive regulators of Fgf8 expression during limb outgrowth; they are ectodermal targets of Fgf10 signaling from the mesenchyme. Dominant-negative overexpression in chick and morpholino knockdown in zebrafish both abolish Fgf8 expression and impair limb outgrowth, demonstrating their requirement. Wnt/beta-catenin signaling positively regulates Sp8 but not Sp9.\",\n      \"method\": \"Embryological and genetic analyses, chick overexpression and dominant-negative approaches, zebrafish morpholino knockdown, in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal approaches (gain-of-function, dominant-negative, morpholino KD) replicated across two model organisms with defined molecular readout (Fgf8 expression)\",\n      \"pmids\": [\"15358670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Sp9 is expressed in LGE progenitors and maintained in postmitotic striatopallidal MSNs. Sp9-null mice lose most striatopallidal (D2-type) MSNs due to decreased proliferation of their progenitors and increased Bax-dependent apoptosis, while striatonigral neurons are largely unaffected. ChIP-qPCR shows Ascl1 directly binds the Sp9 promoter. RNA-seq/ISH reveal Sp9 promotes expression of Adora2a, P2ry1, Gpr6, and Grik3 in the LGE and striatum.\",\n      \"method\": \"Sp9-null mouse genetic analysis, ChIP-qPCR, RNA-seq, in situ hybridization, immunofluorescence\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic null mouse with defined cellular phenotype, ChIP for upstream regulator, RNA-seq for downstream targets, multiple orthogonal methods in one study\",\n      \"pmids\": [\"27452460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SP8 and SP9 coordinately drive expression of the transcription factor Six3 in a spatially restricted domain of the LGE subventricular zone, which is required for D2 MSN production. ChIP-Seq demonstrates SP9 directly binds the promoter and a putative enhancer of Six3. Conditional deletion of Sp8 and Sp9 causes loss of virtually all D2 MSNs due to reduced neurogenesis; Six3 conditional deletion phenocopies this.\",\n      \"method\": \"Conditional knockout mouse genetics (Sp8/Sp9 double mutants), ChIP-Seq (SP9), RNA-seq, in situ hybridization, genetic epistasis (Six3 conditional KO)\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct SP9 ChIP-Seq binding to Six3 locus, genetic epistasis via Six3 conditional KO phenocopy, and conditional double KO with defined molecular and cellular readouts\",\n      \"pmids\": [\"29967281\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Sp8 and Sp9 are co-expressed in neuroblasts and interneurons of the V-SVZ-RMS-OB system. Although Sp9-null mice show no major OB interneuron defect alone, conditional deletion of both Sp8 and Sp9 severely reduces OB interneuron number through defects in neuronal differentiation, tangential and radial migration, and increased cell death. Sp8/Sp9 double mutants fail to express Prokr2 and Tshz1 in newly born neuroblasts.\",\n      \"method\": \"Conditional knockout mouse genetics (Sp8/Sp9 single and double mutants), RNA-Seq, RNA in situ hybridization, cell counting, migration analysis\",\n      \"journal\": \"Cerebral cortex (New York, N.Y. : 1991)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic null and conditional double KO with defined cellular phenotypes (differentiation, migration, apoptosis) and molecular targets identified by RNA-seq\",\n      \"pmids\": [\"28981617\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SP9 is expressed in the MGE subventricular zone and in MGE-derived migrating interneurons. Sp9-null and conditional mutant mice show ~50% reduction in MGE-derived cortical interneurons, ectopic aggregation of MGE-derived neurons in the embryonic ventral telencephalon, and an increased SST+/PV+ ratio. ChIP-Seq and RNA-Seq identify SP9 as a direct transcriptional regulator of Arx, Lhx6, Lhx8, Nkx2-1, Zeb2 (interneuron development factors) and Ackr3, Epha3, St18 (migration genes).\",\n      \"method\": \"Sp9-null and conditional knockout mouse genetics, SP9 ChIP-Seq, RNA-Seq, immunofluorescence, in situ hybridization\",\n      \"journal\": \"Cerebral cortex (New York, N.Y. : 1991)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — SP9 ChIP-Seq defines direct genomic targets, combined with null/conditional KO phenotypic analysis and RNA-seq in single rigorous study\",\n      \"pmids\": [\"29878134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SP8 and SP9 are co-expressed in the SVZ of the dorsal CGE. Conditional knockout of Sp8/9 (Gsx2-Cre or Dlx5/6-CIE lines) causes severe loss of CGE-derived cortical interneurons and migration defects (longer leading processes, ectopic accumulation in the CGE). Sp8/9 coordinately repress expression of Pak3, Robo1, and Slit1 to regulate CGE-derived interneuron migration.\",\n      \"method\": \"Conditional knockout mouse genetics (Gsx2-Cre and Dlx5/6-CIE lines), immunofluorescence, in situ hybridization, RNA-Seq\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — two independent Cre lines both produce consistent phenotypes, molecular targets identified, multiple orthogonal methods\",\n      \"pmids\": [\"31070778\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"SP8 protein is upregulated in MGE mantle zone in Sp9-null mutants. Combined Sp8/Sp9 conditional knockout results in severe loss of PV+ cortical interneurons due to tangential migration defects, more severe than Sp9 single mutants, indicating Sp8 and Sp9 cooperate. Sp8/Sp9 activity regulates MGE-derived cortical interneuron migration at least through controlling EphA3, Ppp2r2c, and Rasgef1b expression.\",\n      \"method\": \"Sp9-null and Sp8/Sp9 conditional knockout mouse genetics, immunofluorescence, RNA-Seq, migration analysis\",\n      \"journal\": \"Frontiers in molecular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional double KO with defined migration phenotype and molecular targets, single lab, no ChIP confirmation of direct regulation\",\n      \"pmids\": [\"31001083\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Sp9-positive LGE progenitors produce both D1-MSNs and D2-MSNs, but Sp9 expression is rapidly downregulated in postmitotic D1-MSNs. Sustained Sp9 expression (gain-of-function) in LGE progenitors and descendants promotes D2-MSN identity and represses D1-MSN identity, causing an imbalance between D1- and D2-MSNs. Fate-changed D2-like MSNs survive normally in adulthood.\",\n      \"method\": \"Genetic fate mapping, gain-of-function (sustained Sp9 expression) mouse model, immunofluorescence, in situ hybridization\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo gain-of-function with defined cell-fate outcome, single lab, two orthogonal methods (fate mapping + immunofluorescence)\",\n      \"pmids\": [\"35773249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"De novo heterozygous SP9 variants cause interneuronopathy. SP9 missense variants affecting glutamate 378 (within the conserved DNA-binding domain) result in severe epileptic encephalopathy via hypomorphic and neomorphic DNA-binding effects, demonstrated by in vitro assays. SP9 loss-of-function variants result in milder neurodevelopmental phenotype. This establishes that altered SP9 DNA-binding activity directly causes disease.\",\n      \"method\": \"In silico and in vitro assays of SP9 variant DNA-binding activity, patient cohort variant analysis, international data-sharing\",\n      \"journal\": \"Genetics in medicine : official journal of the American College of Medical Genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro DNA-binding assays for specific variants, single study, mechanistic distinction between hypomorphic/neomorphic effects established experimentally\",\n      \"pmids\": [\"38288683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Sp9 was identified as a key regulator of visual thalamic fate through in silico predictions and in vivo perturbations in a spatiotemporal single-cell multiomic atlas of the embryonic mouse thalamus, indicating Sp9 governs sensory lineage specification within the thalamus.\",\n      \"method\": \"Single-cell multiomic atlas, spatial transcriptomics, barcoding-based lineage tracing, in vivo perturbations\",\n      \"journal\": \"bioRxiv (preprint)\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — preprint, in vivo perturbations described but methods are not detailed in the abstract, single study\",\n      \"pmids\": [\"bio_10.1101_2025.07.17.665342\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"SP9 is a Krüppel-like/SP-family zinc-finger transcription factor that directly binds DNA (including the Six3 locus and other target promoters/enhancers) to regulate multiple steps of GABAergic interneuron and medium spiny neuron development: it controls progenitor proliferation, neuronal differentiation, tangential migration, and cell survival in LGE, MGE, and CGE progenitor domains, promotes D2-MSN identity while repressing D1-MSN identity, and is itself transcriptionally activated by Ascl1 (via direct promoter binding) and by Fgf10/Wnt signaling during limb/AER development; loss-of-function or neomorphic mutations in its conserved DNA-binding domain cause human interneuronopathy.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SP9 is an SP-family zinc-finger transcription factor that directly binds DNA to orchestrate multiple steps of GABAergic neuron development across the ventral telencephalon [#2, #4]. In the lateral ganglionic eminence it acts together with SP8 to drive a Six3-dependent neurogenic program — SP9 binds the Six3 promoter and a putative enhancer by ChIP-Seq — that is required to generate striatopallidal D2-type medium spiny neurons; loss of Sp9 (or of both Sp8 and Sp9) eliminates most D2-MSNs through reduced progenitor proliferation and Bax-dependent apoptosis, while sustained SP9 expression promotes D2-MSN identity and represses D1-MSN identity [#1, #2, #7]. SP9 is itself a direct downstream target of Ascl1, which binds its promoter [#1]. In the medial and caudal ganglionic eminences SP9, with SP8, controls cortical interneuron number, subtype balance, and tangential migration, acting as a direct transcriptional regulator of interneuron-fate genes (Arx, Lhx6, Lhx8, Nkx2-1, Zeb2) and migration genes (Ackr3, Epha3, St18), and repressing the migration regulators Pak3, Robo1, and Slit1 [#4, #5, #6]. The same SP8/SP9 partnership governs olfactory bulb interneuron differentiation and migration through targets including Prokr2 and Tshz1 [#3]. De novo heterozygous SP9 variants affecting glutamate 378 in the conserved DNA-binding domain cause severe epileptic encephalopathy through hypomorphic and neomorphic effects on DNA binding, establishing that altered SP9 DNA-binding activity directly causes human interneuronopathy [#8]. Beyond the nervous system, SP9 functions in the apical ectodermal ridge as a positive regulator of Fgf8 expression downstream of Fgf10 signaling during limb outgrowth [#0].\",\n  \"teleology\": [\n    {\n      \"year\": 2004,\n      \"claim\": \"Established the first developmental function of Sp9, placing it in the Fgf10\\u2192ectoderm\\u2192Fgf8 relay that sustains limb outgrowth.\",\n      \"evidence\": \"Chick gain-of-function and dominant-negative, zebrafish morpholino knockdown, in situ hybridization, with Fgf8 expression as readout\",\n      \"pmids\": [\"15358670\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DNA targets at the Fgf8 locus not defined\", \"Relationship to its later neural roles unaddressed\", \"No mammalian limb genetics\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Defined Sp9 as required for striatopallidal D2-MSN production and identified it as a direct Ascl1 target, linking an upstream proneural input to a specific neuronal output.\",\n      \"evidence\": \"Sp9-null mouse phenotyping, ChIP-qPCR (Ascl1 on Sp9 promoter), RNA-seq and ISH for downstream genes\",\n      \"pmids\": [\"27452460\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct SP9 DNA targets not yet mapped in this study\", \"Mechanism distinguishing proliferation from survival defects unresolved\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Resolved the molecular logic of D2-MSN neurogenesis by showing SP8/SP9 directly activate Six3, with Six3 deletion phenocopying the double mutant.\",\n      \"evidence\": \"Sp8/Sp9 conditional double KO, SP9 ChIP-Seq on Six3 promoter/enhancer, RNA-seq, Six3 conditional KO epistasis\",\n      \"pmids\": [\"29967281\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether SP8 and SP9 bind cooperatively or independently at Six3 not resolved\", \"Full SP9 cistrome beyond Six3 not enumerated here\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Extended SP8/SP9 function to olfactory bulb interneurons, showing redundancy and a role in differentiation, migration, and survival.\",\n      \"evidence\": \"Sp8/Sp9 single and conditional double KO mice, RNA-seq, ISH, cell counting, migration analysis\",\n      \"pmids\": [\"28981617\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct vs indirect regulation of Prokr2/Tshz1 not established by ChIP\", \"Single-mutant tolerance reflects unquantified redundancy\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mapped the direct SP9 cistrome in the MGE, establishing it as a hub controlling interneuron-fate and migration gene programs.\",\n      \"evidence\": \"Sp9-null/conditional KO, SP9 ChIP-Seq, RNA-Seq, immunofluorescence, ISH\",\n      \"pmids\": [\"29878134\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Which targets drive subtype (SST/PV) balance vs migration not dissected\", \"Cofactors at SP9-bound sites unidentified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Showed SP8/SP9 act in the CGE as repressors of a Slit/Robo migration module, broadening their domain of action to a third progenitor zone.\",\n      \"evidence\": \"Conditional KO with two independent Cre lines (Gsx2-Cre, Dlx5/6-CIE), immunofluorescence, ISH, RNA-Seq\",\n      \"pmids\": [\"31070778\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding to Pak3/Robo1/Slit1 loci not shown\", \"Mechanism of repression unknown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrated functional cooperation between Sp8 and Sp9 in MGE-derived PV interneuron migration, with SP8 upregulation partly compensating for Sp9 loss.\",\n      \"evidence\": \"Sp9-null and Sp8/Sp9 conditional KO mice, immunofluorescence, RNA-Seq, migration analysis\",\n      \"pmids\": [\"31001083\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No ChIP confirmation of direct regulation of EphA3/Ppp2r2c/Rasgef1b\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established that the level and persistence of SP9 acts as a switch between D2 and D1 MSN identity rather than only affecting MSN number.\",\n      \"evidence\": \"Genetic fate mapping and sustained Sp9 gain-of-function mouse model, immunofluorescence, ISH\",\n      \"pmids\": [\"35773249\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct repressive targets enforcing D1 identity not identified\", \"Single lab, no biochemical mechanism for the switch\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Connected SP9 DNA-binding activity directly to human disease, distinguishing hypomorphic loss-of-function from neomorphic missense effects.\",\n      \"evidence\": \"Patient cohort variant analysis with in silico and in vitro DNA-binding assays for E378 and LoF variants\",\n      \"pmids\": [\"38288683\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Neomorphic target rewiring not defined at genomic scale\", \"No animal model of the E378 variant\", \"Single study\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Proposed an additional role for Sp9 in visual thalamic sensory lineage specification, outside the established telencephalic GABAergic program.\",\n      \"evidence\": \"Single-cell multiomic atlas, spatial transcriptomics, lineage barcoding and in vivo perturbations (preprint)\",\n      \"pmids\": [\"bio_10.1101_2025.07.17.665342\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Preprint, perturbation methods not detailed\", \"Direct targets in thalamus unknown\", \"Not independently confirmed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How SP9 and SP8 physically partition direct genomic targets, and what cofactors mediate their context-specific activation versus repression, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No reported SP8\\u2013SP9 biochemical interaction map\", \"Cofactor identity at SP9 binding sites unknown\", \"Structural basis of neomorphic DNA binding undetermined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 4, 8]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2, 4, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 2, 4, 5]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 4]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"SP8\", \"ASCL1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"tie","faith_supported":7,"faith_total":7,"faith_pct":100.0}}